Location: Home
  • search
  • go
  • Relate News
  • 5/11/2022China Rolls Out Five Year Plan to Develop $3.28 Trillion Bioeconomy ...
  • 5/11/2022NMPA Issues the 14th FYP for Drug Regulatory Network Safety and IT Bui...
  • 5/11/2022Review of Top 10 Listed Chinese Biotech Firms by R&D Spending in 2021
  • 5/10/2022NMPA Issues Two Guidelines for TCM Registration and Evaluation
  • 5/10/2022NMPA Solicits Comments on the Draft Implementation Rules for Drug Admi...
  • 5/10/2022Coherus Biosciences Terminates Deal With Innovent for Avastin Biosimil...
  • 5/9/2022SMEI: Review of Chinese Terminal Drug Markets in 2011 – 2021
  • 5/9/2022China's Pharma Companies Are Spending Big on R&D, But Global Success R...
  • 5/9/2022Chugai's Defeat in Patent Linkage Case Spotlights Invalidation Proceed...
  • 5/6/2022Trends in Innovative Drug Development in China (Nature)
  • 5/6/2022Upcoming Event: PHARM Connect Congress
  • 5/6/2022China Grants Approval and Generic Drug Status to CSPC's Alzheimer's Di...
  • 5/6/2022Orion Enters into Exclusive Deal with Jemincare for Novel Non-Opioid D...
  • 5/6/2022Drug R&D and Product Registration News Digest May 2022 (1)
  • 5/6/2022Recent Executive Moves
  • 5/5/2022EyePoint Signs Expanded License Deal with Betta Pharma for EYP-1901 in...
  • 5/5/2022China's 88 firms Including Sinovac Added to SEC List for Possible Deli...
  • 5/4/2022NiKang and Hansoh Announce Strategic Collaboration and License Deal fo...
  • 5/4/2022Intravacc Enters Licensing Deal with Zhifei Lvzhu Biopharma for Whoopi...
  • 5/4/2022BeiGene/Amgen Granted CN Conditional Approval of BLINCYTO (Blinatumo...
  • 5/4/2022How American Companies are Approaching China's Data, Privacy, and Cybe...
  • 5/3/2022International Cooperation Under China's Proposed Implementing Rules Fo...
  • 5/3/2022Navigating The Latest Changes In China's Regulation Of Human Genetic R...
  • 5/2/2022China in Lockdown Mode … Are Long Term Prospects and Bright Spots Sti...
  • 5/2/2022China Continues to Drop Reimbursements via DIP system: PBM
  • 5/2/2022U.S. FDA Snubs Two More China Only-Tested New Drugs from Hutchmed and ...
  • 5/2/2022Merck's MilliporeSigma Invests €100M to Accelerate Single-Use Manufac...
  • 5/2/2022Former GSK Scientist Convicted of Stealing Trade Secrets To Benefit Ch...
  • 5/2/2022Pfizer Wins Chinese Approval of lorlatinib for ALK-positive Advanced N...
  • 4/29/2022Novartis Reports Performance in Q1/2022 with China Business Up 16%
  • Page:85/719 Total number of articles:21546: [First][<<] [83] [84] [85] [86] [87] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group